vs
Side-by-side financial comparison of Blue Foundry Bancorp (BLFY) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $13.3M, roughly 1.0× Blue Foundry Bancorp). Blue Foundry Bancorp runs the higher net margin — -27.4% vs -342.3%, a 314.9% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 34.2%).
Blue Foundry Bancorp is a regional bank holding company based in New Jersey, United States. It offers a comprehensive range of personal and commercial banking products, including deposit accounts, consumer loans, mortgage services, and business financing solutions, serving local individual consumers and small to medium-sized enterprises.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
BLFY vs GOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $13.8M |
| Net Profit | $-3.5M | $-47.2M |
| Gross Margin | — | — |
| Operating Margin | — | -333.6% |
| Net Margin | -27.4% | -342.3% |
| Revenue YoY | 34.2% | 47.1% |
| Net Profit YoY | -30.6% | -43.0% |
| EPS (diluted) | $-0.18 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $13.8M | ||
| Q3 25 | $12.6M | $13.3M | ||
| Q2 25 | $12.0M | — | ||
| Q1 25 | $11.1M | — | ||
| Q4 24 | $9.9M | — | ||
| Q3 24 | $9.5M | — | ||
| Q2 24 | $10.1M | $95.8M | ||
| Q1 24 | $9.9M | $0 |
| Q4 25 | $-3.5M | $-47.2M | ||
| Q3 25 | $-1.9M | $-48.2M | ||
| Q2 25 | $-2.0M | — | ||
| Q1 25 | $-2.7M | — | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | $-2.3M | $49.2M | ||
| Q1 24 | $-2.8M | $-41.9M |
| Q4 25 | — | -333.6% | ||
| Q3 25 | — | -369.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | — |
| Q4 25 | -27.4% | -342.3% | ||
| Q3 25 | -14.8% | -362.7% | ||
| Q2 25 | -16.2% | — | ||
| Q1 25 | -24.2% | — | ||
| Q4 24 | -28.4% | — | ||
| Q3 24 | -42.7% | — | ||
| Q2 24 | -23.2% | 51.4% | ||
| Q1 24 | -28.8% | — |
| Q4 25 | $-0.18 | $-0.21 | ||
| Q3 25 | $-0.10 | $-0.21 | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.19 | — | ||
| Q2 24 | $-0.11 | $0.22 | ||
| Q1 24 | $-0.13 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.1M | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $312.7M | $-122.8M |
| Total Assets | $2.2B | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.1M | $136.9M | ||
| Q3 25 | $44.1M | $180.2M | ||
| Q2 25 | $41.9M | — | ||
| Q1 25 | $46.2M | — | ||
| Q4 24 | $42.5M | — | ||
| Q3 24 | $76.1M | — | ||
| Q2 24 | $60.3M | $354.5M | ||
| Q1 24 | $53.8M | $244.4M |
| Q4 25 | $312.7M | $-122.8M | ||
| Q3 25 | $314.4M | $-82.3M | ||
| Q2 25 | $321.3M | — | ||
| Q1 25 | $326.7M | — | ||
| Q4 24 | $332.2M | — | ||
| Q3 24 | $339.3M | — | ||
| Q2 24 | $345.6M | $81.5M | ||
| Q1 24 | $350.2M | $26.7M |
| Q4 25 | $2.2B | $172.2M | ||
| Q3 25 | $2.2B | $208.8M | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.0B | $373.4M | ||
| Q1 24 | $2.0B | $259.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.0M | $-48.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.0M | $-48.3M | ||
| Q3 25 | $-255.0K | $-36.2M | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $-3.8M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $14.1M | $116.3M | ||
| Q1 24 | $-4.9M | $-52.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-4.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 49.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -49.3% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.36× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
